Industry under fire for failing to develop new antibiotics
17 September 2009
Ian Schofield
Please Login to read the full article.
17 September 2009
Ian Schofield
Despite the continuing growth in antibiotic resistance, few novel antibacterial agents are under development and those that are tend to be targeted at bacteria for which treatments already exist.
The problem is now so severe that in the EU about 25,000 people die each year from...
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA reviewers question proposed study design for Salix's Xifaxan in IBS
- Rib-X Pharma files for IPO to finance antibiotics providing superior coverage
- IMI plans "unprecedented" programme for novel antibiotics as drug resistance continues to rise
- US Capitol Capsule: Use of mind-altering medicines in children, elderly under fire
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- Chinese producers may be losing price edge to India, says Granules MD
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
